Industries
Gene Therapy
Gene therapy delivers genetic fixes for inherited and acquired diseases using viral vectors and genome editing. It recruits molecular biologists and bioengineers from academia and frequently licenses university-developed editing and delivery technologies.
Details
- Companies
- Spark TherapeuticsSarepta TherapeuticsBioMarinuniQureSangamo TherapeuticsIntellia TherapeuticsBeam TherapeuticsEditas MedicineKrystal BiotechSolid Biosciences
- Market Size
- $95B
- Target Researchers
- Molecular biologists and bioengineers in viral vectors, genome editing, delivery, and translational medicine
- Use Cases
- AAV vector-engineering R&D hiringCRISPR delivery partnershipsUniversity gene-therapy-lab spin-outsGMP and translational talent pipelineRare-disease research collaborations